Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment

Psychosomatics

Volumn 45, Issue 5, 2004, Pages 419-425

  Iosifescu, Dan V ^a   Nierenberg, Andrew A ^a   Alpert, Jonathan E ^a   Papakostas, George I ^a   Perlis, Roy H ^a   Sonawalla, Shamsah ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANGER; ANXIETY; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; RELAPSE; REMISSION; SELF REPORT;

EID: 3142745792     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.45.5.419     Document Type: Article

References (29)

1. Wells KB, Golding JM, Burnam MA: Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145:976-981
2. Crum RM, Cooper-Patrick L, Ford DE: Depressive symptoms among general medical patients: prevalence and one-year outcome. Psychosom Med 1994; 56:109-117
3. Patten SB: Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry 1999; 44:151-157
4. Koenig HG, Meador KG, Cohen HJ, Blazer DG: Depression in elderly hospitalized patients with medical illness. Arch Intern Med 1988; 148:1929-1936
5. Koenig HG, Meador KG, Shelp F, Goli V, Cohen HJ, Blazer DG: Major depressive disorder in hospitalized medically ill patients: an examination of young and elderly male veterans. J Am Geriatr Soc 1991; 39:881-890
6. Ganzini L, Smith DM, Fenn DS, Lee MA: Depression and mortality in medically ill older adults. J Am Geriatr Soc 1997; 45:307-312
7. Akiskal H: Factors associated with incomplete recovery in primary depressive illness. J Clin Psychiatry 1982; 43:266-271
8. Keitner GI, Ryan CE, Miller IW, Kohn R, Epstein NB: 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). Am J Psychiatry 1991; 148:345-350
9. Swindle RW, Cronkite RC, Moos RH. Risk factors for sustained nonremission of depressive symptoms: a 4-year follow-up. J Nerv Ment Dis 1998; 186:462-469
10. Popkin MK, Callies AL, Mackenzie TB: The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 1985; 42:1160-1163
11. Evans M, Hammond M, Wilson K, Lye M, Copeland J: Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 1997; 12:817-824
12. Evans M, Hammond M, Wilson K, Lye M, Copeland J: Treatment of depression in the elderly: effect of physical illness on response. Int J Geriatr Psychiatry 1997; 12:1189-1194
13. Oslin DW, Datto CJ, Kallan MJ, Katz IR, Edell WS, TenHave T: Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 2002; 50:823-828
14. Alexopoulos GS, Meyers BS, Robert YC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J: Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57:285-290
15. Koike AK, Unutzer J, Wells KB: Improving the care for depression in patients with comorbid medical illness. Am J Psychiatry 2002; 159:1738-1745
16. Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF: Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol 2002; 22:379-387
17. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). New York, New York State Psychiatric Institute, Biometrics Research, 1989
18. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48:851-855
19. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
20. Linn BS, Linn MW, Gurel L: Cumulative illness rating scale. J Am Geriatr Soc 1968; 16:622-626
21. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF 3rd: Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41:237-248
22. Kellner RA: A symptom questionnaire. J Clin Psychiatry 1987; 48:268-274
23. Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, Martin-Santos R, Santiso A, Noguera R, Casais L, Perez-Camo V, Arias M, Judge R, Fluoxetine Long-Term Study Group: Fluoxetine in the prevention of depressive recurrences: a double-blind study. J Clin Psychopharmacol 2001; 21:417-424
24. Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160:3278-3285
25. DeVane CL: Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999; 19:443-466
26. Meyers CA: Mood and cognitive disorders in cancer patients receiving cytokine therapy, in Cytokines, Stress and Depression. Edited by Danzer R, Wollman EE, Yirmiya R. New York, Kluwer Academic/Plenum Publishers, 1999, 75-81
27. Danzer R, Wollman E, Vitkovic L, Yirmiya R: Cytokines and depression: fortuitous or causative association. Mol Psychiatry 1999; 4:328-332
28. Extermann M: Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000; 35:181-200
29. Lyness JM, Caine ED, Conwell Y, King DA, Cox C: Depressive symptoms, medical illness, and functional status in depressed psychiatric inpatients. Am J Psychiatry 1993; 150:910-915